Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.50
+0.29 (1.91%)
At close: Feb 27, 2026, 4:00 PM EST
15.77
+0.27 (1.74%)
After-hours: Feb 27, 2026, 7:47 PM EST
Cullinan Therapeutics Employees
Cullinan Therapeutics had 111 employees as of December 31, 2024. The number of employees increased by 26 or 30.59% compared to the previous year.
Employees
111
Change (1Y)
26
Growth (1Y)
30.59%
Revenue / Employee
n/a
Profits / Employee
-$1,953,270
Market Cap
915.68M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 111 | 26 | 30.59% | 111 | 0 |
| Dec 31, 2023 | 85 | 23 | 37.10% | 85 | 0 |
| Dec 31, 2022 | 62 | 31 | 100.00% | 62 | 0 |
| Mar 31, 2022 | 37 | 13 | 54.17% | 37 | 0 |
| Dec 31, 2021 | 31 | 7 | 29.17% | 31 | 0 |
| Sep 30, 2021 | 33 | 15 | 83.33% | 33 | 0 |
| Jun 30, 2021 | 28 | 11 | 64.71% | 28 | 0 |
| Mar 31, 2021 | 24 | 7 | 41.18% | 24 | 0 |
| Dec 31, 2020 | 24 | - | - | 24 | 0 |
| Sep 30, 2020 | 18 | - | - | 17 | 1 |
| Jun 30, 2020 | 17 | - | - | 16 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 700 |
| Maravai LifeSciences Holdings | 550 |
| Xencor | 250 |
| uniQure | 209 |
| ARS Pharmaceuticals | 167 |
| CytomX Therapeutics | 121 |
| Theravance Biopharma | 97 |
| ArriVent BioPharma | 52 |
CGEM News
- 5 days ago - Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - Cullinan Therapeutics: Thesis Strengthening For This T-Cell Engager Specialist - Seeking Alpha
- 10 days ago - Cullinan Therapeutics, Inc. (CGEM) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript - Seeking Alpha
- 11 days ago - Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - GlobeNewsWire
- 24 days ago - Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 4 weeks ago - Cullinan Therapeutics: Cash-Rich Biotech With Multiple Value Drivers - Seeking Alpha
- 7 weeks ago - Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones - GlobeNewsWire
- 2 months ago - Cullinan Therapeutics, Inc. (CGEM) Discusses Initial CLN-049 Results and Development Strategy for AML Applications Transcript - Seeking Alpha